Page last updated: 2024-12-08

n-propyl-4-phenyl-1,2,3,6-tetrahydropyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-propyl-4-phenyl-1,2,3,6-tetrahydropyridine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID146272
CHEMBL ID317826
MeSH IDM0123960

Synonyms (12)

Synonym
CHEMBL317826 ,
pptp
4-phenyl-1-propyl-1,2,3,6-tetrahydro-pyridine
bdbm50003594
4-phenyl-1-propyl-1,2,3,6-tetrahydropyridine
n-propyl-4-phenyl-1,2,3,6-tetrahydropyridine
pyridine, 1,2,3,6-tetrahydro-4-phenyl-1-propyl-, erythro-
90986-85-9
CKRLIWFOVCLXTP-UHFFFAOYSA-N
pyridine, 1,2,3,6-tetrahydro-1-propyl-4-phenyl-
4-phenyl-1-propyl-1,2,3,6-tetrahydropyridine #
DTXSID80238344
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Amine oxidase [flavin-containing] BBos taurus (cattle)Ki5,000.00000.05401.83906.0000AID126376
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
primary amine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
monoamine oxidase activityAmine oxidase [flavin-containing] BBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
mitochondrionAmine oxidase [flavin-containing] BBos taurus (cattle)
mitochondrial outer membraneAmine oxidase [flavin-containing] BBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID17444Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.1992Journal of medicinal chemistry, Oct-30, Volume: 35, Issue:22
Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors.
AID401023Activity of human liver MAOB assessed as specific activity at 1 mM
AID127348Binding affinity towards monoaminooxidase Relative to MPTP1993Journal of medicinal chemistry, Oct-01, Volume: 36, Issue:20
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
AID126372Monoamine oxidase B Inactivation property expressed as inactivation constant (K inact) was determined at a concentration of 300-1500 uM1992Journal of medicinal chemistry, Oct-30, Volume: 35, Issue:22
Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors.
AID22832Kinetic parameter Vmax/K (Litres/min/unit of MAO-B) for the MAO-B catalyzed oxidation of the compound.1992Journal of medicinal chemistry, Oct-30, Volume: 35, Issue:22
Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors.
AID126376Inhibitory constant against monoamine Oxidase(MAO-B) was determined at a concentration of 300-1500 uM1992Journal of medicinal chemistry, Oct-30, Volume: 35, Issue:22
Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors.
AID22611Kinetic parameter Vmax (nm/min/unit of MAO-B) for the MAO-B catalyzed oxidation of the compound.1992Journal of medicinal chemistry, Oct-30, Volume: 35, Issue:22
Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors.
AID126530Ratio of Kcat and KM against monoamine oxidase B (MAO-B) from beef liver was calculated1996Journal of medicinal chemistry, Sep-13, Volume: 39, Issue:19
Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.64 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]